63 - Estrogen Deprivation in Survivors of Breast Cancer: Potential Long-term Consequences & Symptom Management
Monday, April 6, 2020
10:50 AM – 11:20 AM
Location: Forum 137
Anti-estrogen therapy is an important treatment for women with hormone receptor-positive breast cancer, resulting in substantial risk reduction and improvements in survival. However, these treatments can lead to symptoms and potential long-term adverse consequences related to early estrogen deprivation. This talk will review the data regarding the risk of breast cancer recurrence and mortality with the use of menopausal hormone therapy as well as non-hormonal approaches to management of vasomotor symptoms.
Explain the potential adverse long-term consequences of early estrogen deprivation in breast cancer survivors.
Discuss the evidence regarding the risk of breast cancer recurrence and associated mortality with the use of MHT.
Review practice considerations for use of menopausal hormone therapy in breast cancer survivors. List nonhormonal therapies for management of vasomotor symptoms.